PCLO.V - PharmaCielo Ltd.
| Previous Close | 4.90 |
| Open | 4.90 |
| Bid | 4.97 x 0 |
| Ask | 4.99 x 0 |
| Day's Range | 4.65 - 5.06 |
| 52 Week Range | 4.02 - 11.50 |
| Volume | 162,009 |
| Avg. Volume | 135,128 |
| Market Cap | 482.37M |
| Beta (3Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.42 |
| Earnings Date | Nov 25, 2019 - Dec 5, 2019 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 8.47 |
- The Motley Fool
1 Newly Listed Weed Stock Could Bring You Riches
If you want to bet on a cannabis IPO that could earn you a fortune in the future, PharmaCielo Ltd. (TSXV:PCLO) is a sound choice. This premier cultivator of medicinal-grade cannabis has all the right elements to prosper in the highly competitive cannabis industry.
CNW GroupPharmaCielo Announces Financial Results for the Second Quarter 2019
Well capitalized with a cash and short-term investments of $33.2 million as of June 30, 2019 Subsequent to quarter completed first commercial export of CBD from Colombia to Europe Have cleared all regulatory ...
CNW GroupPharmaCielo's Very First Commercial CBD Export from Colombia Lands in Europe
TORONTO and CHAM, Switzerland, Aug. 19, 2019 /CNW/ - PharmaCielo Ltd. ("PharmaCielo" or the "Company") (TSXV:PCLO, OTC:PHCEF), the Canadian parent of Colombia's premier cultivator and producer of medicinal-grade cannabis oil, PharmaCielo Colombia Holdings S.A.S., confirmed today it successfully completed the first commercial export of CBD isolate to Europe. The inaugural shipment of the high quality CBD isolate, a key ingredient in various cannabis derived therapeutic, nutraceutical, topicals and lifestyle products, was delivered to the Swiss headquarters of Creso Pharma, a global pharmaceutical with expertise in cannabis- and hemp-derived products for human and veterinarian use.
CNW GroupPharmaCielo Expands Further Into Latin America With Sales Agreement to Supply CBD Extracts, Oils and Veterinary Products to Laboratorios Adler
TORONTO and MONTEVIDEO, Uruguay, Aug. 13, 2019 /CNW/ - PharmaCielo Ltd. ("PharmaCielo" or the "Company") (TSXV:PCLO, OTC:PHCEF), the Canadian parent of Colombia's premier cultivator and producer of medicinal-grade cannabis oil, PharmaCielo Colombia Holdings S.A.S., announced it has signed a sales agreement with Uruguay-based Laboratorios Adler ("Adler"). According to the agreement, PharmaCielo will provide Adler with bulk CBD extracts, bulk and bottled CBD oils and veterinary products that will be sold by Adler in Uruguay, Paraguay, Bolivia and Southern Brazil.
CNW GroupPharmaCielo Joins Canadian Market Cannabis Tracking and Verification Initiative
TORONTO and RIONEGRO, Colombia, Aug. 8, 2019 /CNW/ - PharmaCielo Ltd. ("PharmaCielo" or the "Company") (TSXV:PCLO, OTC:PHCEF), the Canadian parent of Colombia's premier cultivator and producer of medicinal-grade cannabis oil, PharmaCielo Colombia Holdings S.A.S., today announced it has joined the TruTrace Technologies, Inc. ("TruTrace") (CSE:TTT, OTCQB:TTTSF) and Shoppers Drug Mart initiated medical cannabis pilot verification program ("Pilot Program").
- The Motley Fool
Latest Developments Highlight Why It’s Time to Buy PharmaCielo (TSXV:PCLO)
Get ready for PharmaCielo Ltd. (TSXV:PCLO) to soar as commercial production nears.
CNW GroupPharmaCielo Colombia Holdings S.A.S. Appoints New and Diversified Board of Directors
New board consists of diversified experts with domestic and international business, academia, agriculture, trade and healthcare expertise Half of new board members are businesswomen, reflecting the overall ...
CNW GroupPharmaCielo Achieves Twelvefold Increase in Dried Cannabis Processing Capacity to Meet Global Demand for Medicinal Oil Extracts
TORONTO and RIONEGRO, Colombia, Aug. 1, 2019 /CNW/ - PharmaCielo Ltd. ("PharmaCielo" or the "Company") (TSXV:PCLO, OTC:PHCEF), the Canadian parent of Colombia's premier cultivator and producer of medicinal-grade cannabis oil, PharmaCielo Colombia Holdings S.A.S., is ramping up its oil processing capabilities in the Company's Rionegro, Colombia facility following the recent acquisition and installation of additional high-performance, high-volume extractors, combined with proprietary extraction techniques.
- Market Exclusive
PharmaCielo to Begin Export of CBD Extracts from Colombia
PharmaCielo Ltd. (TSXV: PCLO) (OTC: PHCEF), the Canadian parent of Colombia's cultivator and producer of medicinal-grade cannabis extracts PharmaCielo Colombia Holdings S.A.S., announced that it has completed the necessary permitting process required to enable Colombia's first commercial export and sale of non-psychoactive (CBD) isolate. The process fulfills the extensive and final regulatory obligations required, including […]The post PharmaCielo to Begin Export of CBD Extracts from Colombia appeared first on Market Exclusive.
- Market Exclusive
Cannabis Stock News Daily Roundup July 29
iAnthus Capital Holdings (CSE: IAN) (OTCQX: ITHUF) has reported several recent milestones in Massachusetts. The company’s Mayflower Medicinals was approved for a retail marijuana license by the City of Worcester License Commission to operate an adult-use dispensary. The company's medical marijuana cultivation and processing facility in Holliston is supplying flower, pre-rolls, distillate, and edibles to Mayflower’s […]The post Cannabis Stock News Daily Roundup July 29 appeared first on Market Exclusive.
CNW GroupPharmaCielo Completes Acquisition of Ubiquo Telemedicina
TORONTO, July 26, 2019 /CNW/ - PharmaCielo Ltd. ("PharmaCielo" or the "Company") (TSXV:PCLO), the Canadian parent of Colombia's premier cultivator and producer of medicinal-grade cannabis oil, PharmaCielo Colombia Holdings S.A.S., today announced that it has completed the acquisition of all of the shares (the "Acquisition") of Ubiquo Telemedicina S.A.S. ("Ubiquo Telemedicina"), previously announced on April 20, 2018.
CNW GroupPharmaCielo First to Receive Colombian Government Export Approval for Commercial Sale of CBD Isolate
Completion of commercial export permit process clears the way for PharmaCielo to initiate shipment of its medicinal-grade CBD extracts to wholesale distributors and product manufacturers CBD isolate to ...
CNW GroupPharmaCielo Colombia Holdings S.A.S. Appoints Andres Felipe Botero as Chief Operations Officer
RIONEGRO, Colombia, July 22, 2019 /CNW/ - PharmaCielo Colombia Holdings S.A.S. ("PharmaCielo Colombia" or the "Company"), the premier cultivator and producer of medicinal-grade cannabis oils and extracts in Colombia and subsidiary of Canadian firm PharmaCielo Ltd. (TSXV:PCLO, OTC:PHCEF), is pleased to announce the appointment of Andres Felipe Botero as Chief Operations Officer (COO).
- Simply Wall St.
PharmaCielo Ltd. (CVE:PCLO): When Will It Breakeven?
PharmaCielo Ltd.'s (CVE:PCLO): PharmaCielo Ltd., through its subsidiary, PharmaCielo Colombia Holdings S.A.S...
- GlobeNewswire
Blueberries Medical Makes Significant Advances Towards Commercial Production & Provides Operational and Corporate Update
Expansion of Cultivation Facilities: Newly constructed open-air greenhouses completed and fully operational, increasing initial production capacity by approximately 40% to 150,000 sq.ft. Upgrade to facility infrastructure, including irrigation and electrical systems, water reservoirs and propagation facility also completed. Extraction: Customized extraction line with capacity to process up to 75,000 kg/year of dried flower currently undergoing specializations and customization to meet EU-GMP standards. Strategic Partnerships: Announced several strategic partnerships including (i) an agreement with SLANG Worldwide (CSE:SLNG) (“Slang”) announced on July 11, 2019 to license their extensive portfolio of CPG (Consumer Packaged Goods) products and leverage Slang’s industry leading know-how and intellectual property to process and formulate cannabis products in Colombia and Argentina, (ii) a distribution agreement announced on February 14, 2019 with El Manantial, a local medical center network and (iii) a European distribution agreement announced on June 5, 2019.
- The Motley Fool
Legal Cannabis Cultivation in Colombia: Rising Risks and Overplayed Hype
PharmaCielo Ltd's (TSXV:PCLO) acquisition of Creso Pharma Ltd. allows it to sidestep the issues preventing Colombia's legal marijuana industry from taking off.
- The Motley Fool
Colombian Cannabis IPOs Follow in the Footsteps of the Oil Industry
Is Khiron Life SciencesCorp. (TSXV:KHRN) shaping up to become a takeover target?
- The Motley Fool
Colombia: The Next Major Threat to Canada’s Burgeoning Cannabis Industry
Get ready for PharmaCielo Ltd. (TSXV:PCLO) to soar once it commences production in Colombia.
- The Motley Fool
Want to Cash in on the Marijuana Boom? My Top Cannabis Stock to Buy in June
Buy Colombian cannabis cultivator PharmaCielo Ltd. (TSXV:PCLO) today before it soars.
CNW GroupPharmaCielo Announces Trading on the OTC Market
TORONTO and RIONEGRO, Colombia, June 21, 2019 /CNW/ - PharmaCielo Ltd. ("PharmaCielo" or the "Company") (TSXV:PCLO) (OTC:PHCEF), the Canadian parent of Colombia's premier cultivator and producer of medicinal-grade cannabis oil, PharmaCielo Colombia Holdings S.A.S., is pleased to announce that it is trading on the OTC Markets under the symbol "PHCEF". "With our recently announced acquisition agreement with Creso Pharma (ASX:CPH.AX - News) there is increased attention and interest in our stock. Trading on the OTC will increase access for U.S. and international investors, providing greater liquidity and better access to capital. As we move forward building a global medicinal cannabis company, we will work to provide easy access and liquidity for investors in all jurisdictions," said David Attard, Chief Executive Officer of PharmaCielo Ltd.
- The Motley Fool
Colombia: Poised to Become the World’s Leading Cannabis Growing Jurisdiction
PharmaCielo Ltd. (TSXV:PCLO) is ready to soar after making a transformative acquisition.
- CNW Group
IIROC Trading Resumption - PCLO
VANCOUVER , June 6, 2019 /CNW/ - Trading resumes in: Company: Pharmacielo Ltd. TSX-Venture Symbol: PCLO (all issues) Resumption (ET): 11:00 AM IIROC can make a decision to impose a temporary suspension ...
CNW GroupPharmaCielo to Acquire International Cannabis Company Creso Pharma for A$122 Million
TORONTO, June 6, 2019 /CNW/ - PharmaCielo Ltd. ("PharmaCielo" or the "Company") (TSXV:PCLO), the Canadian parent of Colombia's premier cultivator and producer of medicinal-grade cannabis oil, PharmaCielo Colombia Holdings S.A.S., today announced that it has entered into a scheme implementation agreement (the "Implementation Agreement") pursuant to which PharmaCielo has agreed to acquire all of the issued and outstanding shares and listed options of Creso Pharma Ltd. ("Creso Pharma") (ASX:CPH.AX - News), for an aggregate purchase price of approximately A$122 million (the "Acquisition"). Creso Pharma is a global medicinal cannabis company that specializes in research, development and production of therapeutic, nutraceutical and animal health products. PharmaCielo will pay A$0.63 per Creso Pharma share, representing a premium of 50% over the closing trading price of the Creso Pharma shares on May 31, 2019.
- CNW Group
IIROC Trading Halt - PCLO
VANCOUVER , June 6, 2019 /CNW/ - The following issues have been halted by IIROC: Company: Pharmacielo Ltd. TSX-Venture Symbol: PCLO (All Issues) Reason: At the Request of the Company Pending News Halt ...
CNW GroupPharmaCielo Gears Up for U.S. Market Demand, Enlists Former Congressman and Medical Cannabis Advocate Dana Rohrabacher as a Special Advisor
TORONTO, May 29, 2019 /CNW/ - PharmaCielo Ltd. ("PharmaCielo" or the "Company") (TSXV:PCLO), the Canadian parent of Colombia's premier cultivator and producer of medicinal-grade cannabis oil, PharmaCielo Colombia Holdings S.A.S., announced today that it has enlisted former U.S. congressman and long-time medical cannabis advocate Dana Rohrabacher as a special advisor to the Company.
